NewsMarkets

Health

Correction Published For Study On Muscarinic Agents In Schizophrenia Treatment

A correction has been issued for a paper discussing dopamine synthesis and acetylcholine in the context of new muscarinic agents.

1 publisher · 1 article · first seen 12 Oct 2026 · updated 2d ago

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 12 Oct 2026. Molecular Psychiatry published first, on 12 October at 00:00 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Correction: “Increasing dopamine synthesis capacity in the dorsal striatum and tonic acetylcholine: implications for the new muscarinic agents in the treatment of schizophrenia” Molecular Psychiatry ·
Embed this story

Paste this into any web page to show the live odds, with a link back here.